Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study.

Int J Urol · 2021 · PMC8453930 · PMID 34148264

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0870

boldest claim

The sentences

did not reach statistical significanceP = 0.05actually significant

19 Although the tendency was similar in the tertile analysis in the PROSTAT‐BSI study, the difference between groups with high and low BSI did not reach statistical significance ( P = 0.05–0.10).

also in 98,063 other papers

borderline significanceP = 0.054so close (0.05 < p ≤ 0.1)

Survival differed only in the mHSPC group with a borderline significance ( P = 0.054), and groups with BSI of <0.9 and 0.9–3.5 did not significantly differ (Fig. 3 ).

also in 6,432 other papers

borderline significantP = 0.087so close (0.05 < p ≤ 0.1)

The same variables were associated with death among patients with mCRPC (Table 3 ), whereas multivariate proportional hazards analysis found that none of the variables were significant, and CRP was borderline significant ( P = 0.087).

also in 10,359 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.